Development, Evaluation, and Molecular Docking of Oral Dissolving Film of Atenolol.
Karina Citra RaniNani ParfatiNi Luh Dewi AryaniAgnes Nuniek WinantariEndang Wahyu FitrianiAditya Trias PradanaRoisah NawatilaAstridani Rizky PutrantiFlorencia IrineFlorentia AngelicaCintya YohanesChristina AvantiPublished in: Pharmaceutics (2021)
The development of oral dissolving film (ODF) of atenolol is an attempt to enhance convenience and compliance for geriatric patients suffering from hypertension. Film former is the most essential component in ODF that determines the physical characteristic and drug release. In this study, three different types of film former including HPMC E5 4% (w/v), 5% (w/v), CMC-Na 3% (w/v), 4% (w/v), and Na-alginate 2.5% (w/v), 3% (w/v) were optimized in Formula 1 (F1) to Formula 6 (F6), respectively. A solvent casting method was employed to develop ODF of atenolol. The films formed by HPMC E5 produced a smooth and flexible surface, whereas CMC-Na and Na-alginate produced gritty textured films. Satisfactory results were obtained from several physical parameters such as film thickness, folding endurance, swelling index, and disintegration time. The homogeneity, drug content, and dissolution properties of ODF with HPMC exhibited better characteristics than the other formulas. Formula 1 exhibited the highest drug release compared to the other ODFs. The molecular docking results showed that there was a hydrogen bonding between atenolol and film formers which was also supported by the FTIR spectrum. The findings of this study suggest that HPMC E5 is the most favorable film former for ODF of atenolol.
Keyphrases
- molecular docking
- room temperature
- drug release
- reduced graphene oxide
- molecular dynamics simulations
- drug delivery
- mental health
- physical activity
- ionic liquid
- ejection fraction
- end stage renal disease
- human milk
- gold nanoparticles
- skeletal muscle
- resistance training
- high intensity
- peritoneal dialysis
- patient reported outcomes
- preterm birth
- patient reported